Analyst Ratings for DexCom (DXCM)
DXCM Rating Summary
DXCM Price Target Summary
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$13.17 (-37.6%)
Avg. $ Target:
$13.17 (-37.6%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/30/2012 | Raymond James | New Coverage | Outperform (N/A) |
15.00 (N/A) |
12.70 | 21.12 | 66.3% | Details |
| 10/18/2012 | Northland Securities | New Coverage | Market Perform (N/A) |
12.00 (N/A) |
14.11 | 21.12 | 49.68% | Details |
| 4/18/2012 | Avondale Partners | New Coverage | Market Outperform (N/A) |
12.50 (N/A) |
9.64 | 21.12 | 119.09% | Details |
| 4/2/2012 | Leerink Swann | New Coverage | Market Perform (N/A) |
12.00 (N/A) |
10.43 | 21.12 | 102.49% | Details |
| 1/17/2012 | Brean Capital » Updated 2/24/2012 |
New Coverage | Buy (N/A) |
13.50 (N/A) |
10.01 | 21.12 | 110.99% | Details |
| 1/11/2012 | McNicoll Lewis & Vlak | Downgrade | Hold (N/A) |
N/A (N/A) |
8.86 | 21.12 | 138.37% | Details |
| 12/29/2011 | Wunderlich Securities | New Coverage | Buy (N/A) |
12.00 (N/A) |
8.54 | 21.12 | 147.31% | Details |
| 11/18/2011 | Capstone Investments | Upgrade | Buy (N/A) |
8.50 (N/A) |
7.00 | 21.12 | 201.71% | Details |
| 11/3/2011 | SunTrust Robinson Humphrey | Downgrade | Reduce (N/A) |
N/A (N/A) |
7.45 | 21.12 | 183.49% | Details |
| 11/3/2011 | Morgan Keegan | Downgrade | Market Perform (N/A) |
N/A (N/A) |
7.45 | 21.12 | 183.49% | Details |
| 10/28/2011 | Feltl & Co | Downgrade | Hold (N/A) |
10.70 (N/A) |
9.40 | 21.12 | 124.68% | Details |
| 5/18/2011 | Oppenheimer | New Coverage | Perform (N/A) |
N/A (N/A) |
15.14 | 21.12 | 39.5% | Details |
| 3/29/2011 | Jefferies » Updated 11/2/2012 |
New Coverage | Buy (N/A) |
16.50 (18.00) |
14.83 | 21.12 | 42.41% | Details |
| 1/12/2011 | Noble Financial | Downgrade | Hold (N/A) |
N/A (N/A) |
14.01 | 21.12 | 50.75% | Details |
| 12/1/2010 | Weeden & Co | New Coverage | Buy (N/A) |
N/A (N/A) |
11.49 | 21.12 | 83.81% | Details |
